Gritstone Bio Inc (GRTS)
0.9559
-0.01
(-0.71%)
USD |
NASDAQ |
May 06, 16:00
0.9594
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Enterprise Value: 55.28M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 55.28M |
| May 02, 2024 | 46.19M |
| May 01, 2024 | 46.55M |
| April 30, 2024 | 39.32M |
| April 29, 2024 | 39.92M |
| April 26, 2024 | 40.64M |
| April 25, 2024 | 35.84M |
| April 24, 2024 | 40.59M |
| April 23, 2024 | 33.30M |
| April 22, 2024 | 33.98M |
| April 19, 2024 | 33.11M |
| April 18, 2024 | 33.80M |
| April 17, 2024 | 33.95M |
| April 16, 2024 | 36.57M |
| April 15, 2024 | 33.33M |
| April 12, 2024 | 43.35M |
| April 11, 2024 | 51.30M |
| April 10, 2024 | 53.67M |
| April 09, 2024 | 56.85M |
| April 08, 2024 | 59.92M |
| April 05, 2024 | 56.01M |
| April 04, 2024 | 62.37M |
| April 03, 2024 | 77.57M |
| April 02, 2024 | 78.55M |
| April 01, 2024 | 191.32M |
| Date | Value |
|---|---|
| March 28, 2024 | 212.90M |
| March 27, 2024 | 235.45M |
| March 26, 2024 | 214.86M |
| March 25, 2024 | 224.67M |
| March 22, 2024 | 229.57M |
| March 21, 2024 | 236.43M |
| March 20, 2024 | 228.59M |
| March 19, 2024 | 226.63M |
| March 18, 2024 | 203.09M |
| March 15, 2024 | 194.27M |
| March 14, 2024 | 180.54M |
| March 13, 2024 | 192.30M |
| March 12, 2024 | 207.01M |
| March 11, 2024 | 197.21M |
| March 08, 2024 | 220.74M |
| March 07, 2024 | 214.86M |
| March 06, 2024 | 174.65M |
| March 05, 2024 | 160.92M |
| March 04, 2024 | 169.75M |
| March 01, 2024 | 158.96M |
| February 29, 2024 | 234.11M |
| February 28, 2024 | 238.01M |
| February 27, 2024 | 227.28M |
| February 26, 2024 | 199.95M |
| February 23, 2024 | 177.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-43.28M
Minimum
May 25 2022
1.118B
Maximum
Jan 22 2021
172.90M
Average
137.41M
Median
Enterprise Value Benchmarks
| Precision BioSciences Inc | -21.51M |
| Humacyte Inc | 444.71M |
| Verastem Inc | 178.81M |
| BioVie Inc | 9.521M |
| Adial Pharmaceuticals Inc | 4.066M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.82M |
| Revenue (Quarterly) | 0.029M |
| Total Expenses (Quarterly) | 30.50M |
| EPS Diluted (Quarterly) | -0.26 |
| Profit Margin (Quarterly) | -106.3K% |
| Earnings Yield | -126.3% |
| Normalized Earnings Yield | -126.30 |